YC,MDs Xopenex experience,& JNJ considered buyout upon profit-
messages 1100 & 1102-:
bbeckord
(56/M/boulder,colorado)
06/29/1999 11:52 am EDT
I adminstered Xopenex to a patient in my emergency room last night who indicated he was allergic to
albuterol in the past. He was a 76 y/o male with severe COPD with difficulty breathing. The patient
had developed tingling in his mouth, irritation in his eyes, tachycardia, and a dramatic reduction in his
PEFR to the point of needing intubation. His symptoms disappeared when albuterol was withdrawn
and atrovent adminstered.
I had him on a monitor, so I decided to give him an SVN of Xopenex. With one adminstration of
Xopenex, his PEFR went from 180 to 300, he had no tingling in his mouth, his heart rate did not
increase, and he showed no signs of tremor. This drug certainly does work, and if we only need to
adminster it every 8 hours, it will be a big success.
At the annual meeting, Barberich indicated J&J had looked at buying the company, but elected to
pass until Sepracor is profitable. They want any purchase to be accretive to earnings. J&J indicated
they would look at them at a later date.
Also, he said they would like to split the stock if it goes above $100.00. They want to put the stock in
the hands of more individual investors and be less susceptible to the vagaries of institutions. They are
going to do more road shows this year to help diversify their investors.
__________________________________________________________________
Buyout
bbeckord
(56/M/boulder,colorado)
06/29/1999 01:05 pm EDT
It came from the horses mouth in conversations immediately after the formal part of the annual
meeting. |
